LENZ Therapeutics, Inc. (LENZ) Financials

LENZ Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 272.5 million 26.0 million
Dec. 31, 2025 305.9 million 21.5 million
Sept. 30, 2025 210.7 million 16.8 million
June 30, 2025 217.3 million 11.0 million

LENZ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -33.6 million 4.3 million
Dec. 31, 2025 -33.1 million 3.7 million
Sept. 30, 2025 -9.0 million 3.5 million
June 30, 2025 -11.7 million 2.8 million

LENZ Net Income

No data available :(

LENZ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 258.4 million 237000 -
Dec. 31, 2025 292.3 million 350000 815000
Sept. 30, 2025 202.2 million 461000 954000
June 30, 2025 209.5 million - 1.1 million

LENZ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 31.4 million
Dec. 31, 2025 31.1 million
Sept. 30, 2025 28.5 million
June 30, 2025 28.1 million

LENZ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 18000 - 44.8 million -
Dec. 31, 2025 38000 - 39.5 million -
Sept. 30, 2025 439000 3.8 million 27.5 million -
June 30, 2025 240000 9.1 million 12.8 million -

LENZ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.9 million 1.2 million
Dec. 31, 2025 1.6 million 525000
Sept. 30, 2025 12.5 million 125000
June 30, 2025 5.0 million 19000

LENZ Revenue by Segment
Graph available only for paid members. Upgrade to see it.

LENZ

Price: $7.01

52 week price:
6.65
50.40

Earnings Per Share: -3.64 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 230.1 million

Links: